Shanghai Model Organisms Center, Inc. engages research and development, production, sale, and related technical services of genetically modified animal models....
SMOC: Net profit of 18.1674 million yuan in the first half of 2025, year-on-year growth not applicable
Pharmaceutical stocks show divergence during trading, with Cosunter experiencing a significant drop
SMOC: Stock has risen more than 30% for two consecutive days
SMOC: Haiwang Hezong acquired 8.6797 million shares of the company
The concept of assisted reproduction rebounds after hitting the bottom, Leadman rises over 15%
Some shareholders of SMOC plan to transfer a total of 11.13% of the company's shares to Haiwang Hezhong